Crossref journal-article
Springer Science and Business Media LLC
Nature Medicine (297)
Bibliography

Vlodavsky, I., Friedmann, Y., Elkin, M., Aingorn, H., Atzmon, R., Ishai-Michaeli, R., Bitan, M., Pappo, O., Peretz, T., Michal, I., Spector, L., & Pecker, I. (1999). Mammalian heparanase: Gene cloning, expression and function in tumor progression and metastasis. Nature Medicine, 5(7), 793–802.

Authors 12
  1. Israel Vlodavsky (first)
  2. Yael Friedmann (additional)
  3. Michael Elkin (additional)
  4. Helena Aingorn (additional)
  5. Ruth Atzmon (additional)
  6. Rivka Ishai-Michaeli (additional)
  7. Menachem Bitan (additional)
  8. Orit Pappo (additional)
  9. Tuvia Peretz (additional)
  10. Israel Michal (additional)
  11. Larissa Spector (additional)
  12. Iris Pecker (additional)
References 50 Referenced 645
  1. Kjellen, L. & Lindahl, U. Proteoglycans: structures and interactions. Annu. Rev. Biochem. 60, 443– 475 (1991). (10.1146/annurev.bi.60.070191.002303) / Annu. Rev. Biochem. by L Kjellen (1991)
  2. David, G. Integral membrane heparan sulfate proteoglycan. FASEB J. 7, 1023–1030 (1993). (10.1096/fasebj.7.11.8370471) / FASEB J. by G David (1993)
  3. Jackson, R.L., Busch, S.J. & Cardin, A.L. Glycosaminoglycans: Molecular properties, protein interactions and role in physiological processes. Physiol. Rev. 71, 481–539 (1991). (10.1152/physrev.1991.71.2.481) / Physiol. Rev. by RL Jackson (1991)
  4. Wight, T.N., Kinsella, M.G. & Qwarnstromn, E.E. The role of proteoglycans in cell adhesion, migration and proliferation. Curr. Opin. Cell Biol. 4, 793–801 (1992). (10.1016/0955-0674(92)90102-I) / Curr. Opin. Cell Biol. by TN Wight (1992)
  5. Rapraeger, A.C. The coordinated regulation of heparan sulfate, syndecans and cell behavior. Curr. Opin. Cell Biol. 5, 844– 853 (1993). (10.1016/0955-0674(93)90034-N) / Curr. Opin. Cell Biol. by AC Rapraeger (1993)
  6. Wight, T.N. Cell biology of arterial proteoglycans. Arteriosclerosis 9, 1–20 (1989). (10.1161/01.ATV.9.1.1) / Arteriosclerosis by TN Wight (1989)
  7. Vlodavsky, I., Fuks, Z., Bar-Ner, M., Ariav, Y. & Schirrmacher, V. Lymphoma cell mediated degradation of sulfated proteoglycans in the subendothelial extracellular matrix: Relationship to tumor cell metastasis. Cancer Res. 43, 2704–2711 (1983). / Cancer Res. by I Vlodavsky (1983)
  8. Nakajima, M., Irimura, T., DiFerrante, D., DiFerrante, N. & Nicholson, G.L. Heparan sulfate degradation: relation to tumor invasion and metastatic properties of mouse B16 melanoma sublines. Science 220, 611– 613 (1983). (10.1126/science.6220468) / Science by M Nakajima (1983)
  9. Nakajima, M., Irimura, T. & Nicolson, G.L. Heparanase and tumor metastasis. J. Cell. Biochem. 36, 157–167 (1988). (10.1002/jcb.240360207) / J. Cell. Biochem. by M Nakajima (1988)
  10. Vlodavsky, I. et al. Inhibition of tumor metastasis by heparanase inhibiting species of heparin. Invasion Metastasis 14, 290– 302 (1995). / Invasion Metastasis by I Vlodavsky (1995)
  11. Parish, C.R., Coombe, D.R., Jakobsen, K.B. & Underwood, P.A. Evidence that sulphated polysaccharides inhibit tumor metastasis by blocking tumor cell-derived heparanase. Int. J. Cancer 40, 511–517 (1987). (10.1002/ijc.2910400414) / Int. J. Cancer by CR Parish (1987)
  12. Lider, O. et al. Suppression of experimental autoimmune diseases and prolongation of allograft survival by treatment of animals with heparinoid inhibitors of T lymphocyte heparanase. J. Clin. Invest. 83, 752–756 (1989). (10.1172/JCI113953) / J. Clin. Invest. by O Lider (1989)
  13. Willenborg, D. O. & Parish, C. R. Inhibition of allergic encephalomyelitis in rats by treatment with sulfated polysaccharides. J. Immunol. 140, 3401– 3405 (1988). (10.4049/jimmunol.140.10.3401) / J. Immunol. by DO Willenborg (1988)
  14. Vlodavsky, I. et al. Expression of heparanase by platelets and circulating cells of the immune system: Possible involvement in diapedesis and extravasation. Invasion Metastasis 12, 112– 127 (1992). / Invasion Metastasis by I Vlodavsky (1992)
  15. Graham, L.D. & Underwood, P.A. Comparison of the heparanase enzymes from mouse melanoma cells, mouse macrophages and human platelets. Biochem. Mol. Biol. 39, 563– 571 (1996). / Biochem. Mol. Biol. by LD Graham (1996)
  16. Ishai-Michaeli, R., Eldor, A. & Vlodavsky, I. Heparanase activity expressed by platelets, neutrophils and lymphoma cells releases active fibroblast growth factor from extracellular matrix. Cell Reg. 1, 833– 842 (1990). (10.1091/mbc.1.11.833) / Cell Reg. by R Ishai-Michaeli (1990)
  17. Vlodavsky, I., Bar-Shavit, R., Ishai-Michaeli, R., Bashkin, P. & Fuks, Z. Extracellular sequestration and release of fibroblast growth factor: a regulatory mechanism? Trends Biochem. Sci. 16, 268–271 (1991). (10.1016/0968-0004(91)90102-2) / Trends Biochem. Sci. by I Vlodavsky (1991)
  18. Eisenberg, S., Sehayek, E., Olivecrona, T. & Vlodavsky, I. Lipoprotein lipase enhances binding of lipoproteins to heparan sulfate on cell surfaces and extracellular matrix. J. Clin. Invest. 90, 2013–2021 (1992). (10.1172/JCI116081) / J. Clin. Invest. by S Eisenberg (1992)
  19. Oosta, G.M., Favreau, L.V., Beeler, D.L. & Rosenberg, R.D. Purification and properties of human platelet heparitinase. J. Biol. Chem. 257, 11249–11255 (1982). (10.1016/S0021-9258(18)33749-9) / J. Biol. Chem. by GM Oosta (1982)
  20. Freeman, C. & Parish, C.R. Human platelet heparanase: Purification, characterization and catalytic activity. Biochem. J. 330, 1341–1350 (1998). (10.1042/bj3301341) / Biochem. J. by C Freeman (1998)
  21. Hoogewerf, A.J. et al. CXC chemokines connective tissue activating peptide-III and neutrophil activating peptide-2 are heparin/heparan sulfate-degrading enzymes. J. Biol. Chem. 270, 3268– 3277 (1995). (10.1074/jbc.270.7.3268) / J. Biol. Chem. by AJ Hoogewerf (1995)
  22. Gonzalo, V. et al. Partial sequence of human platelet heparitinase and evidence of its ability to polymerize. Biochim. Biophys. Acta 1429, 431–438 (1999). (10.1016/S0167-4838(98)00254-4) / Biochim. Biophys. Acta by V Gonzalo (1999)
  23. Jin, L., Nakajima, M. & Nicolson, G.L. Immunochemical localization of heparanase in mouse and human melanoma. Int. J. Cancer 45, 1088–1095 (1990). (10.1002/ijc.2910450618) / Int. J. Cancer by L Jin (1990)
  24. De Vouge, M.W. et al. Immunoselection of GRP94/Endoplasmin from a KNRK cell specific g gt11 library using antibodies directed against a putative heparanase amino-terminal peptide. Int. J. Cancer 56, 286– 294 (1994). (10.1002/ijc.2910560224) / Int. J. Cancer by MW De Vouge (1994)
  25. Goshen, R. et al. Purification and characterization of placental heparanase and its expression by cultured cytotrophoblasts. Mol. Hum. Reprod. 2, 679–684 (1996). (10.1093/molehr/2.9.679) / Mol. Hum. Reprod. by R Goshen (1996)
  26. Bar-Ner, M., Eldor, A., Wasserman, L., Matzner, Y. & Vlodavsky, I. Inhibition of heparanase mediated degradation of extracellular matrix heparan sulfate by modified and non-anticoagulant heparin species. Blood 70, 551–557 (1987). (10.1182/blood.V70.2.551.551) / Blood by M Bar-Ner (1987)
  27. Even-Ram, S. et al. Thrombin receptor overexpression in malignant and physiological invasion processes. Nature Med. 8, 909– 914 (1998). (10.1038/nm0898-909) / Nature Med. by S Even-Ram (1998)
  28. Larizza, L., Schirrmacher, V. & Pfluger, E. Acquisition of high metastatic capacity after in vitro fusion of a non-metastatic tumor line with a bone marrow derived macrophage. J. Exp. Med. 160, 1579– 1584 (1984). (10.1084/jem.160.5.1579) / J. Exp. Med. by L Larizza (1984)
  29. Klein, U. & Figura, K.V. Substrate specificity of a heparan-sulfate degrading endoglucuronidase from human placenta. Hoppe-Seyler's Z Physiol. Chem. 360, 1465–1471 (1979). (10.1515/bchm2.1979.360.2.1465) / Hoppe-Seyler's Z Physiol. Chem. by U Klein (1979)
  30. Bame, K. J., & Robson K. Heparanases produce distinct populations of heparan sulfate glycosaminoglycans in Chinese hamster ovary cells. J. Biol. Chem. 272, 2245–2251 (1997). (10.1074/jbc.272.4.2245) / J. Biol. Chem. by KJ Bame (1997)
  31. Sandback-Pikas, D., Li, J-P., Vlodavsky, I. & Lindahl, U. Substrate specificity of heparanases from human hepatoma and platelets. J. Biol. Chem. 273, 18770–18777 (1998). (10.1074/jbc.273.30.18770) / J. Biol. Chem. by D Sandback-Pikas (1998)
  32. Pillarisetti, S. et al. Endothelial cell heparanase modulation of lipoprotein lipase activity. J. Biol. Chem. 272, 15753– 15759 (1997). (10.1074/jbc.272.25.15753) / J. Biol. Chem. by S Pillarisetti (1997)
  33. Yahalom, J., Eldor, A., Fuks, Z. & Vlodavsky, I. Degradation of sulfated proteoglycans in the subendothelial extracellular matrix by human platelet heparitinase. J. Clin. Invest. 74, 1842–1849 (1984). (10.1172/JCI111603) / J. Clin. Invest. by J Yahalom (1984)
  34. Bashkin, P., Razin, E., Eldor, A. & Vlodavsky, I. Degranulating mast cells secrete an endoglycosidase which degrades heparan sulfate in subendothelial extracellular matrix. Blood 75, 2204– 2212 (1990). (10.1182/blood.V75.11.2204.2204) / Blood by P Bashkin (1990)
  35. Matzner, Y. et al. Degradation of heparan sulfate in the subendothelial basement membrane by a readily released heparanase from human neutrophils. J. Clin. Invest. 76, 1306–1313 (1985). (10.1172/JCI112104) / J. Clin. Invest. by Y Matzner (1985)
  36. Naparstek, Y., Cohen, I.R., Fuks, Z. & Vlodavsky, I. Activated T lymphocytes produce a matrix-degrading heparan sulfate endoglycosidase. Nature 310, 241–243 (1984). (10.1038/310241a0) / Nature by Y Naparstek (1984)
  37. Peretz, T. et al. Maintenance on extracellular matrix and expression of heparanase activity by human ovarian carcinoma cells from biopsy specimens. Int. J. Cancer 45, 1054–1060 (1990). (10.1002/ijc.2910450613) / Int. J. Cancer by T Peretz (1990)
  38. Kleiner, D. E. & Stetler-Stevenson, W. G. Structural biochemstry and activation of matrix metalloproteases. Curr. Opin. Cell Biol. 5, 891–897 (1993). (10.1016/0955-0674(93)90040-W) / Curr. Opin. Cell Biol. by DE Kleiner (1993)
  39. Stetler-Stevenson, W. G. Type IV collagenases in tumor invasion and metastasis. Cancer Metastasis Rev. 9, 289–303 (1990). (10.1007/BF00049520) / Cancer Metastasis Rev. by WG Stetler-Stevenson (1990)
  40. Mignatti, P. & Rifkin, D. B. Biology and biochemistry of proteinases in tumor invasion. Physiol. Rev. 73, 161–195 (1993). (10.1152/physrev.1993.73.1.161) / Physiol. Rev. by P Mignatti (1993)
  41. Bar-Ner, M. et al. Sequential degradation of heparan sulfate in the subendothelial extracellular matrix by highly metastatic lymphoma cells. Int. J. Cancer 35, 483–491 (1985). (10.1002/ijc.2910350411) / Int. J. Cancer by M Bar-Ner (1985)
  42. Vlodavsky, I. et al. in Tumor Angiogenesis (eds. Lewis, C.E., Bicknell, R &Ferrara, N.) 125–140 (Oxford University Press, Oxford, UK, 1997).
  43. Vlodavsky, I., Bar-Shavit, R., Korner, G. & Fuks, Z. in Basement Membranes: Cellular and Molecular Aspects (eds. Rohrbach, D.H. & Timpl, R.) 327–343 (Academic, Orlando, Florida, 1993). (10.1016/B978-0-12-593165-6.50022-X)
  44. Yayon, A., Klagsbrun, M., Esko, J.D., Leder, P. & Ornitz, D.M. Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor. Cell 64, 841– 848 (1991). (10.1016/0092-8674(91)90512-W) / Cell by A Yayon (1991)
  45. Miao, H-Q., Ornitz, D. M., Eingorn, E., Ben-Sasson, S. A. & Vlodavsky I. Modulation of fibroblast growth factor-2 receptor binding, dimerization, signaling and angiogenic activity by a synthetic heparin-mimicking polyanionic compound. J. Clin. Invest. 99, 1565–1575 (1997). (10.1172/JCI119319) / J. Clin. Invest. by H-Q Miao (1997)
  46. Vlodavsky, I. et al. Endothelial cell-derived basic fibroblast growth factor: Synthesis and deposition into subendothelial extracellular matrix. Proc. Natl. Acad. Sci. USA 84, 2292–2296 (1987). (10.1073/pnas.84.8.2292) / Proc. Natl. Acad. Sci. USA by I Vlodavsky (1987)
  47. Vlodavsky, I. & Christofori, G. in Antiangiogenic Agents in Cancer Therapy (ed. Teicher, B.A.) 93–118 (Humana, Totowa, New Jersey, 1998). (10.1007/978-1-59259-453-5_7)
  48. Soule, H.D. et al. Isolation and characterization of a spontaneously immortalized human breast epithelial cell line, MCF-10. Cancer Res. 50, 6075–6086 (1990). / Cancer Res. by HD Soule (1990)
  49. Vlodavsky, I. in Current protocols in Cell Biology, Vol. I, Suppl. I (eds. Bonifacino, J.S., Dasso, M, Harford, J.B, Lippincott-Schwartz, J & Yamada, K.M.) 10.4.1–10.4.14 (John Wiley & Sons, New York, New York, 1999).
  50. Savitsky, K. et al. Ataxia-telangiectasia: structural diversity of untranslated sequences suggests complex post-translational regulation of ATM gene expression. Nucleic Acids Res. 25, 1678– 1684 (1997). (10.1093/nar/25.9.1678) / Nucleic Acids Res. by K Savitsky (1997)
Dates
Type When
Created 23 years, 1 month ago (July 26, 2002, 4:43 a.m.)
Deposited 2 years, 4 months ago (April 20, 2023, 7:35 p.m.)
Indexed 18 minutes ago (Sept. 6, 2025, 12:51 p.m.)
Issued 26 years, 2 months ago (July 1, 1999)
Published 26 years, 2 months ago (July 1, 1999)
Published Online 26 years, 2 months ago (July 1, 1999)
Published Print 26 years, 2 months ago (July 1, 1999)
Funders 0

None

@article{Vlodavsky_1999, title={Mammalian heparanase: Gene cloning, expression and function in tumor progression and metastasis}, volume={5}, ISSN={1546-170X}, url={http://dx.doi.org/10.1038/10518}, DOI={10.1038/10518}, number={7}, journal={Nature Medicine}, publisher={Springer Science and Business Media LLC}, author={Vlodavsky, Israel and Friedmann, Yael and Elkin, Michael and Aingorn, Helena and Atzmon, Ruth and Ishai-Michaeli, Rivka and Bitan, Menachem and Pappo, Orit and Peretz, Tuvia and Michal, Israel and Spector, Larissa and Pecker, Iris}, year={1999}, month=jul, pages={793–802} }